Tülin Öztürk
Tülin Öztürk
Cerrahpaşa Tıp Fakültesi, İstanbul Üniversitesi
Verified email at
Cited by
Cited by
Corticosteroid treatment in the management of idiopathic granulomatous mastitis to avoid unnecessary surgery
T Mizrakli, M Velidedeoglu, M Yemisen, B Mete, F Kilic, H Yilmaz, T Ozturk, ...
Surgery Today 45 (4), 457-465, 2015
Ex vivo assessment of sentinel lymph nodes in breast cancer using shear wave elastography
F Kilic, M Velidedeoglu, T Ozturk, SG Kandemirli, AS Dikici, ME Er, ...
Journal of Ultrasound in Medicine 35 (2), 271-277, 2016
192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer
O ÖZTÜRK, ÖF KAĞNICI, T ÖZTÜRK, H Durak, BM Tüzüner, ...
Anticancer Research 29 (10), 4041-4046, 2009
Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature
T Basturk, A Ozagarı, T Ozturk, R Kusaslan, A Unsal
Journal of Renal Care 35 (3), 147-150, 2009
The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population
T Öztürk, ÖT Kahraman, B Toptaş, HI Kisakesen, C Cakalir, L Verim, ...
in vivo 25 (4), 663-668, 2011
Positron emission tomography/computed tomography imaging of brown tumors mimicking multiple skeletal metastases in patient with primary hyperparathyroidism
S Sager, A Aliyev, M Halac, T Oztürk
Indian journal of endocrinology and metabolism 16 (5), 850, 2012
Investigation of BRAF V600E mutation in papillary thyroid carcinoma and tumor-surrounding nontumoral tissues
A Dağlar-Aday, B Toptaş, T Öztürk, F Seyhan, N Saygılı, AP Eronat, ...
DNA and cell biology 32 (1), 13-18, 2013
Primary breast carcinomas with neuroendocrine features: Clinicopathological features and analysis of tumor growth patterns in 36 cases
CK Talu, C Leblebici, TK Ozturk, E Hacihasanoglu, SB Koca, Z Gucin
Annals of Diagnostic Pathology 34, 122-130, 2018
Different propolis samples, phenolic content, and breast cancer cell lines: Variable cytotoxicity ranging from ineffective to potent
MF Seyhan, E Yılmaz, Ö Timirci‐Kahraman, N Saygılı, Hİ Kısakesen, ...
IUBMB life 71 (5), 619-631, 2019
CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility
BM Tüzüner, T Öztürk, HI Kisakesen, Ş Ilvan, C Zerrin, O Öztürk, T Isbir
in vivo 24 (1), 71-74, 2010
Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group
S Sager, B Vatankulu, E Erdogan, S Mut, S Teksoz, T Ozturk, ...
Endocrine 50 (1), 138-145, 2015
Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population
YK ÖZBEK, T ÖZTÜRK, BM Tüzüner, Z Calay, S Ilvan, FM Seyhan, ...
Anticancer research 30 (7), 2885-2889, 2010
Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography
S Sager, B Vatankulu, OE Sahin, F Cınaral, L Uslu, A Baran, T Ozturk, ...
Journal of Cancer Research and Therapeutics 14 (5), 989, 2018
Dual inhibition of wound healing and oxidative process by montelukast in experimental colon anastomoses
E Canbay, B Agachan, T Ozturk, M Giris, O Asoglu, E Balik, D Bugra
Surgical innovation 17 (3), 248-255, 2010
Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population
L Verim, O Timirci-Kahraman, H Akbulut, A Akbas, T Ozturk, S Turan, ...
in vivo 28 (3), 397-402, 2014
Primary angiosarcoma of the breast: Diagnosis with computer-assisted MRI-guided radio-guided occult lesion localization (ROLL) technique
F Kilic, SG Kandemirli, ME Er, M Cingoz, M Velidedeoglu, T Ozturk, ...
Diagnostic and Interventional Imaging 96 (11), 1203-1206, 2015
Evaluation of local CYP17A1 and CYP19A1 expression levels as prognostic factors in postmenopausal invasive ductal breast cancer cases
MB Tüzüner, T Öztürk, AP Eronat, F Seyhan, Hİ Kısakesen, Z Calay, ...
Biochemical genetics 54 (6), 784-802, 2016
Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer
O Timirci-Kahraman, NE Ozkan, S Turan, AA Farooqi, L Verim, T Ozturk, ...
Genetic testing and molecular biomarkers 19 (6), 309-315, 2015
Olgu sunumu: primer dalak kist hidatiği
G Hepgül, D Tihan, P Kocael, Y Doğan, T Öztürk, A Cihan
Turkiye Parazitol Derg 34, 184-6, 2010
Programmed death-ligand-1 expression in non-small cell lung cancer and prognosis
S Şahin, Ş Batur, Ö Aydın, T Öztürk, A Turna, B Öz
Balkan Medical Journal 36 (3), 184, 2019
The system can't perform the operation now. Try again later.
Articles 1–20